Ami Miller

992 total citations
23 papers, 747 citations indexed

About

Ami Miller is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ami Miller has authored 23 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ami Miller's work include Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Erythrocyte Function and Pathophysiology (4 papers). Ami Miller is often cited by papers focused on Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Erythrocyte Function and Pathophysiology (4 papers). Ami Miller collaborates with scholars based in United Kingdom, United States and Italy. Ami Miller's co-authors include Terence H. Rabbitts, Nicolas Béry, Stephen J. Perkins, Ruodan Nan, Jayesh Gor, Azubuike I. Okemefuna, S.B. Carr, Carole J. R. Bataille, Abimael Cruz-Migoni and Angela J. Russell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ami Miller

23 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ami Miller United Kingdom	12	433	196	152	143	76	23	747
Hiroyuki Iijima Japan	15	695 1.6×	217 1.1×	288 1.9×	79 0.6×	44 0.6×	43	919
Zoulika Kherrouche France	19	601 1.4×	113 0.6×	33 0.2×	267 1.9×	66 0.9×	36	1.0k
Madan Katragadda United States	13	403 0.9×	194 1.0×	151 1.0×	37 0.3×	17 0.2×	23	642
J G Levy Canada	11	213 0.5×	123 0.6×	105 0.7×	74 0.5×	93 1.2×	25	816
Huaizu Guo China	18	492 1.1×	415 2.1×	371 2.4×	257 1.8×	14 0.2×	41	988
Scott Steward-Tharp United States	8	213 0.5×	752 3.8×	41 0.3×	405 2.8×	14 0.2×	20	1.3k
Kevin P. Callahan United States	11	1.0k 2.3×	127 0.6×	47 0.3×	186 1.3×	50 0.7×	29	1.5k
Mariano R. Gabri Argentina	21	690 1.6×	546 2.8×	238 1.6×	306 2.1×	81 1.1×	42	1.1k
Lara Maloney United States	17	915 2.1×	145 0.7×	28 0.2×	726 5.1×	22 0.3×	50	1.4k
Karl Kossen United States	11	555 1.3×	49 0.3×	83 0.5×	46 0.3×	78 1.0×	23	1.0k

Countries citing papers authored by Ami Miller

Since Specialization

Citations

This map shows the geographic impact of Ami Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Miller more than expected).

Fields of papers citing papers by Ami Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Miller. The network helps show where Ami Miller may publish in the future.

Co-authorship network of co-authors of Ami Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Ami Miller. A scholar is included among the top collaborators of Ami Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami Miller. Ami Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jing, et al.. (2021). An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells. Leukemia Research. 108. 106626–106626. 8 indexed citations

Béry, Nicolas, Carole J. R. Bataille, Angela J. Russell, et al.. (2021). A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2. Science Advances. 7(15). 11 indexed citations

Tanaka, Tomoyuki, et al.. (2021). Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody. Scientific Reports. 11(1). 1712–1712. 7 indexed citations

Canning, Peter, Carole J. R. Bataille, Nicolas Béry, et al.. (2021). Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds. Journal of Immunological Methods. 494. 113051–113051. 5 indexed citations

Béry, Nicolas, Ami Miller, & Terence H. Rabbitts. (2020). A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS. Nature Communications. 11(1). 3233–3233. 81 indexed citations

Jain, Arvind, et al.. (2020). Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells. ACS Applied Bio Materials. 3(12). 8481–8495. 5 indexed citations

Cruz-Migoni, Abimael, Peter Canning, Camilo Quevedo, et al.. (2019). Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proceedings of the National Academy of Sciences. 116(7). 2545–2550. 101 indexed citations

Pais, Helio, Katia Ruggero, Jing Zhang, et al.. (2019). Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Scientific Reports. 9(1). 5760–5760. 10 indexed citations

Béry, Nicolas, J.E. Debreczeni, J. Breed, et al.. (2019). KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe. Nature Communications. 10(1). 2607–2607. 66 indexed citations

10.

Cruz-Migoni, Abimael, Robin L. Owen, Joanne E. Nettleship, et al.. (2018). Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor. Acta Crystallographica Section F Structural Biology Communications. 74(3). 143–149. 4 indexed citations

11.

Quevedo, Camilo, Abimael Cruz-Migoni, Nicolas Béry, et al.. (2018). Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nature Communications. 9(1). 3169–3169. 98 indexed citations

12.

Nan, Ruodan, et al.. (2018). Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces. Journal of Biological Chemistry. 293(44). 17166–17187. 10 indexed citations

13.

Béry, Nicolas, Abimael Cruz-Migoni, Carole J. R. Bataille, et al.. (2018). BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. eLife. 7. 44 indexed citations

14.

Bao, Leyuan, Abimael Cruz-Migoni, Denis Ptchelkine, et al.. (2017). Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein. Scientific Reports. 7(1). 16869–16869. 9 indexed citations

15.

Perkins, Stephen J., Ruodan Nan, Keying Li, Sanaullah Khan, & Ami Miller. (2011). Complement Factor H–ligand interactions: Self-association, multivalency and dissociation constants. Immunobiology. 217(2). 281–297. 66 indexed citations

16.

Miller, Ami, Anna Evans Phillips, Jayesh Gor, Russell Wallis, & Stephen J. Perkins. (2011). Near-planar Solution Structures of Mannose-binding Lectin Oligomers Provide Insight on Activation of Lectin Pathway of Complement. Journal of Biological Chemistry. 287(6). 3930–3945. 25 indexed citations

17.

Nan, Ruodan, Irene Farabella, Felix Schumacher, et al.. (2011). Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration. Journal of Molecular Biology. 408(4). 714–735. 33 indexed citations

18.

Perkins, Stephen J., Ruodan Nan, Azubuike I. Okemefuna, et al.. (2010). Multiple Interactions of Complement Factor H with Its Ligands in Solution: A Progress Report. Advances in experimental medicine and biology. 703. 25–47. 27 indexed citations

19.

Okemefuna, Azubuike I., Ruodan Nan, Ami Miller, Jayesh Gor, & Stephen J. Perkins. (2009). Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations*. Journal of Biological Chemistry. 285(2). 1053–1065. 107 indexed citations

20.

Goldenberg, Gerald J., L. J. Brandes, W.H. Lau, et al.. (1985). Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity.. PubMed. 69(7-8). 761–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact